...Hello and welcome to Biovica Q4 and full-year presentation. My name is Anders Rylander, and I will be presenting together with the CEO Anders Moren. And here's the agenda for the presentation. We'll start with a short introduction to Biovica, the company and the product. We'll go through the Q4 highlights, and then Anders will do the financial update, and then we will, finally, do a summary and open up for a Q&A session. During the Q&A session, we will have you and Johan Unnerus, our analyst from RedEye, to ask questions, but you could also ask the participants submit questions, using the form in the team's application. And if I should move into to the Biovica introduction, I'll start to talk about our productivity. DiviTum is a tool for measuring cell proliferation from a simple blood sample, and we do that by measuring an enzyme which is closely related to the cell proliferation cycle. This has proven to have several advantages when monitoring treatments for cancer patients as cancer...
